Atrás
Rango del Día
$18.77
$19.90
Rango de 52 Semanas
$6.78
$23.56
Volumen
1,603,050
Promedio 50D / 200D
$20.09
/
$15.36
Cierre Anterior
$19.14
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -58.1 | 0.3 |
| P/B | 3.2 | 2.9 |
| ROE % | -5.8 | 3.7 |
| Net Margin % | -6.8 | 3.8 |
| Rev Growth 5Y % | 7.0 | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$21.00
+6.0%
Low: $17.00
High: $25.00
EPS Futuro
-$0.84
Ingresos Est.
610 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
-$0.36
-$0.37 – -$0.35
|
840 M | 4 |
| FY2029 |
-$0.37
-$0.38 – -$0.36
|
780 M | 4 |
| FY2028 |
-$0.53
-$0.85 – -$0.07
|
710 M | 11 |
Puntos Clave
Revenue grew 7.00% annually over 5 years — modest growth
Debt/Equity of 0.20 — conservative balance sheet
Generating 130.12M in free cash flow
PEG of 0.61 suggests growth is underpriced
Capital efficient — spends only 0.92% of revenue on capex
Crecimiento
Revenue Growth (5Y)
7.00%
Revenue (1Y)5.25%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-5.78%
ROIC-8.72%
Net Margin-6.77%
Op. Margin-17.25%
Seguridad
Debt / Equity
0.20
Current Ratio4.46
Interest Coverage0.00
Valoración
P/E Ratio
-58.12
P/B Ratio3.18
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.25% | Revenue Growth (3Y) | 1.93% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7.00% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 642.82M | Net Income (TTM) | -43.54M |
| ROE | -5.78% | ROA | -4.18% |
| Gross Margin | 69.05% | Operating Margin | -17.25% |
| Net Margin | -6.77% | Free Cash Flow (TTM) | 130.12M |
| ROIC | -8.72% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.20 | Current Ratio | 4.46 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -58.12 | P/B Ratio | 3.18 |
| P/S Ratio | 3.94 | PEG Ratio | 0.61 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.53B | Enterprise Value | 2.21B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 642.82M | 610.79M | 618.73M | 516.41M | 490.49M |
| Net Income | -43.54M | -182.63M | -255.10M | -166.00M | -58.22M |
| EPS (Diluted) | -0.35 | -1.52 | -2.18 | -1.46 | -0.53 |
| Gross Profit | 443.88M | 414.48M | 409.31M | 396.02M | 416.40M |
| Operating Income | -110.89M | -194.56M | -265.33M | -167.94M | -52.91M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.04B | 918.64M | 965.14M | 1.03B | 1.02B |
| Total Liabilities | 245.04M | 208.50M | 224.10M | 223.24M | 201.26M |
| Shareholders' Equity | 796.33M | 710.13M | 741.04M | 805.74M | 817.57M |
| Total Debt | 157.74M | 82.61M | 95.37M | 95.18M | 81.98M |
| Cash & Equivalents | 473.97M | 344.07M | 359.28M | 219.75M | 587.45M |
| Current Assets | 684.45M | 584.39M | 596.02M | 635.04M | 747.59M |
| Current Liabilities | 153.45M | 117.63M | 127.16M | 130.96M | 110.36M |